Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

364 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Appropriateness Criteria for Ureteral Stent Omission following Ureteroscopy for Urinary Stone Disease.
Hiller SC, Daignault-Newton S, Rakic I, Linsell S, Conrado B, Jafri SM, Rubenstein R, Abdelhady M, Fischer CP, Gimenez E, Sarle R, Roberts WW, Maitland C, Yousif R, Elgin R, Galejs L, Konheim J, Leavitt D, Stockall E, Fontera JR, Wolf JS Jr, Hollingsworth JM, Dauw CA, Ghani KR; Michigan Urological Surgery Improvement Collaborative. Hiller SC, et al. Among authors: gimenez e. Urol Pract. 2022 May;9(3):253-263. doi: 10.1097/upj.0000000000000302. Epub 2022 Mar 3. Urol Pract. 2022. PMID: 36051638 Free PMC article.
Estimating SARS-CoV-2 Omicron XBB.1.5 Spike-Directed Functional Antibody Levels From an Anti-Receptor Binding Domain Wuhan-Hu-1-Based Commercial Immunoassay Results.
Sánchez-Simarro Á, Cuevas-Ferrando E, Fernández-Soto D, Grau B, Albert E, Giménez E, Avilés-Alía AI, Rusu L, Geller R, Reyburn HT, Navarro D. Sánchez-Simarro Á, et al. Among authors: gimenez e. J Med Virol. 2025 Jan;97(1):e70130. doi: 10.1002/jmv.70130. J Med Virol. 2025. PMID: 39812228 Free PMC article.
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2025 Jan 4;405(10472):33-49. doi: 10.1016/S0140-6736(24)01927-5. Epub 2024 Dec 17. Lancet. 2025. PMID: 39706209 Clinical Trial.
364 results